Success Metrics

Clinical Success Rate
78.0%

Based on 71 completed trials

Completion Rate
78%(71/91)
Active Trials
19(13%)
Results Posted
87%(62 trials)
Terminated
20(14%)

Phase Distribution

Ph phase_2
17
12%
Ph phase_4
79
54%
Ph early_phase_1
3
2%
Ph not_applicable
10
7%
Ph phase_1
5
3%
Ph phase_3
27
19%

Phase Distribution

8

Early Stage

17

Mid Stage

106

Late Stage

Phase Distribution141 total trials
Early Phase 1First-in-human
3(2.1%)
Phase 1Safety & dosage
5(3.5%)
Phase 2Efficacy & side effects
17(12.1%)
Phase 3Large-scale testing
27(19.1%)
Phase 4Post-market surveillance
79(56.0%)
N/ANon-phased studies
10(7.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.3%

71 of 101 finished

Non-Completion Rate

29.7%

30 ended early

Currently Active

19

trials recruiting

Total Trials

145

all time

Status Distribution
Active(25)
Completed(71)
Terminated(30)
Other(19)

Detailed Status

Completed71
Terminated20
unknown18
Recruiting13
Withdrawn10
Active, not recruiting6

Development Timeline

Analytics

Development Status

Total Trials
145
Active
19
Success Rate
78.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (2.1%)
Phase 15 (3.5%)
Phase 217 (12.1%)
Phase 327 (19.1%)
Phase 479 (56.0%)
N/A10 (7.1%)

Trials by Status

unknown1812%
completed7149%
active_not_recruiting64%
not_yet_recruiting43%
recruiting139%
terminated2014%
withdrawn107%
enrolling_by_invitation21%
suspended11%

Recent Activity

Clinical Trials (145)

Showing 20 of 145 trialsScroll for more
NCT07570940Phase 4

A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery

Not Yet Recruiting
NCT04864210Phase 2

Video-assisted Thoracoscopic Surgery - Exparel Study

Completed
NCT05900427Phase 4

Effects on Postoperative Pain of Liposomal Bupivacaine in Interscalene Blocks for Total Shoulder Arthroplasty Patients

Terminated
NCT07097493Phase 4

Liposomal Bupivacaine vs Perineural Adjuvants in Adductor Canalf and iPACK Blocks in Total Knee Arthroplasty

Not Yet Recruiting
NCT04189783Phase 2

Repeat or Single Quadratus Lumborum Block for the Reduction of Opioid Prescriptions After Surgery in Retroperitoneal Sarcoma Patients ("RESQU-SARC" Trial)

Active Not Recruiting
NCT03854344Phase 4

Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain

Completed
NCT05044468Phase 2

EXPAREL or Lidocane as Local Anesthetic in Patients Undergoing Pleuroscopy With Pleural Biopsy and Indwelling Pleural Catheter Placement

Active Not Recruiting
NCT03214510Phase 3

Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery

Active Not Recruiting
NCT07271979Not Applicable

Liposomal Bupivacaine Versus Ropivacaine for Preperitoneal Infiltration Analgesia in Upper Abdominal Laparotomy

Recruiting
NCT04333095Phase 4

Sternal Block With Liposomal Bupivacaine vs. Saline Prior to Incision in Cardiac Surgery

Completed
NCT06411795Phase 2

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Recruiting
NCT06575699Phase 4

Rectus Sheath Block for Analgesia After Gynecological Laparotomy

Completed
NCT05140499Phase 4

Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations

Terminated
NCT05891613Phase 4

A Study of Liposomal Bupivacaine Versus 0.25% Bupivacaine Hydrochloride Post Breast Reduction

Completed
NCT03599635Phase 4

Pec Infiltration With Liposomal Bupivacaine for Breast Surgery

Completed
NCT07222748Phase 3

A Study of TLC590 for Postsurgical Pain Following Bunionectomy

Recruiting
NCT06179004Phase 3

Supraclavicular Bupivacaine Vs. Supraclavicular Liposomal Bupivacaine for Orthopedic Wrist Surgery

Recruiting
NCT05795413

Quality of Recovery From Mastectomy With and Without PECS Blocks

Active Not Recruiting
NCT05177991Early Phase 1

Post-operative Pain Control-TAP Block Using Exparel vs. Marcaine for Hernia Repairs

Active Not Recruiting
NCT05862792

Liposomal Bupivacaine and Transoral Robotic Surgery

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
145